Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2025 Earnings Call Transcript July 30, 2025
Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.86, expectations were $0.27.
Operator: Good morning, and welcome to Ionis Second Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead up the call. Please go ahead.
D. Wade...
